Parallax Volatility Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,000
Closed -$233K 1765
2024
Q4
$233K Hold
50,000
﹤0.01% 1639
2024
Q3
$347K Hold
50,000
﹤0.01% 1591
2024
Q2
$390K Buy
+50,000
New +$370K ﹤0.01% 1484
2022
Q1
Sell
-105,200
Closed -$3.44M 3058
2021
Q4
$3.44M Sell
105,200
-137,800
-57% -$5.54M ﹤0.01% 1369
2021
Q3
$9.97M Sell
243,000
-159,300
-40% -$5.78M 0.01% 944
2021
Q2
$14.5M Buy
402,300
+170,900
+74% +$6.31M 0.01% 751
2021
Q1
$9.03M Buy
231,400
+58,000
+33% +$2.61M 0.01% 995
2020
Q4
$6.99M Buy
+173,400
New +$7.97M 0.01% 1263

Other funds holding GDRX

Parallax Volatility Advisers's GDRX Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 43,877 shares — an estimated $204K sold.

Parallax Volatility Advisers first reported a position in GDRX in Q4 2020 and held it in 7 quarters. The position peaked at $3.27M in Q2 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 43,877 GoodRx Holdings shares in Q1 2025, an estimated $204K.
  • Parallax Volatility Advisers first reported a position in GoodRx Holdings in Q4 2020 and held it in 7 quarters.
  • Parallax Volatility Advisers's GoodRx Holdings position peaked at $3.27M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.